PCSK9 : un nouveau gène impliqué dans l’hypercholestérolémie familialePCSK9 : a new gene involved in familial hypercholesteremia

Rader DJ, Cohen J, Hobbs HH. Monogenic hypercholesterolemia : New insights in pathogenesis and treatment. J Clin Invest 2003 ; 111 : 1795-803.

Hunt SC, Hopkins PN, Bulka K, et al. Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred. Arterioscler Thromb Vasc Biol 2000 ; 20 : 1089-93.

Varret M, Rabes JP, Saint-Jore B, et al. Third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32. Am J Hum Genet 1999 ; 64 : 1378-87.

Abifadel M, Varret M, Rabes JP, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 2003 ; 34 : 154-6.

Timms KM, Wagner S, Samuels ME, et al. A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree. Hum Genet 2004 ; 114 : 349-53.

Leren TP. Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia. Clin Genet 2004 ; 65 : 419-22.

Seidah NG, Benjannet S, Wickham L, et al. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1) : Liver regeneration and neuronal differentiation. Proc Natl Acad Sci USA 2003 ; 100 : 928-33.

Maxwell KN, Soccio RE, Duncan EM, et al. Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice. J Lipid Res 2003 ; 44 : 2109-19.

Horton JD, Shah NA, Warrington JA, et al. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci USA 2003 ; 100 : 12027-32

Dubuc G, Chamberland A, Wassef H, et al. Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2004 ; 24 : 1-6.

Maxwell KN, Breslow JL. Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype. Proc Natl Acad Sci USA 2004 ; 101 : 7100-5.

Benjannet S, Rhainds D, Essalmani R, et al. NARC-1/PCSK9 and its natural mutants : zymogen cleavage and effects on the LDLR and LDL-cholesterol. J Biol Chem 2004 (sous presse).

Ouguerram K, Chetiveaux M, Zair Y, et al. Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9. Arterioscler Thromb Vasc Biol 2004 ; 24 : 1448-53.

Park SW, Moon YA, Horton JD. Post-transcriptional regulation of LDL receptor protein by proprotein convertase subtilisin/kexin type 9a (PCSK9) in mouse liver. J Biol Chem 2004 (sous presse).